{"database": "openregs", "table": "dockets", "rows": [["FDA-2026-P-0655", "FDA", "Request that the FDA determine that the listed RLD product FENOGLIDE (fenofibrate) Tablets, 40 mg and 120 mg, N022118, NDA Holder\u2013 Salix Pharmaceuticals INC, was not discontinued for safety or effectiveness reasons", "Nonrulemaking", "2026-04-30T16:27:00Z", "0b000064b91758a6"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2026-P-0655"], "units": {}, "query_ms": 0.4300468135625124, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}